Are BMI and adipokines associated with asthma, atopy and lung function in young adults previously hospitalized for

Karen Galta Sørensen1, Knut Øymar1, Grete Jonsson2

  • 1Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.

Respiratory Medicine
|February 8, 2023
PubMed

Insights

Childhood bronchiolitis hospitalization increases adult asthma risk, but BMI and adipokines do not explain this link. Specific adipokine associations with lung function and asthma differed between groups.

Area of Science:

  • Pediatric Respiratory Medicine
  • Adult Pulmonary Health
  • Metabolic Syndrome and Respiratory Disease

Background:

  • Childhood bronchiolitis hospitalization is linked to persistent asthma and reduced lung function in adulthood.
  • The underlying mechanisms connecting early respiratory illness to later lung health remain unclear.
  • Body Mass Index (BMI) and adipokines (hormones regulating fat metabolism) are implicated in respiratory morbidity.

Purpose of the Study:

  • To investigate if associations between BMI, adipokines, and respiratory outcomes (asthma, atopy, lung function) differ in young adults with a history of bronchiolitis compared to controls.
  • To explore the role of metabolic factors in long-term respiratory health after severe infant respiratory illness.

Main Methods:

  • A historical cohort study comparing 185 young adults previously hospitalized for bronchiolitis with 146 matched controls.
  • Cross-sectional measurements of BMI, adiponectin, leptin, resistin, and ghrelin at 17-20 years of age.
  • Regression models and interaction terms were used to analyze associations and group differences in asthma, atopy, and lung function.

Main Results:

  • BMI was associated with asthma and lung function, but these associations did not differ between the post-bronchiolitis and control groups.
  • Adiponectin showed differing associations with forced vital capacity (FVC) between groups (positive in post-bronchiolitis, inverse in controls).
  • Resistin was associated with current asthma only in the control group, with differing associations observed between groups.

Conclusions:

  • The increased prevalence of asthma and impaired lung function in young adults with a history of bronchiolitis do not appear to be explained by growth and fat metabolism.
  • While some adipokine associations differ, overall, BMI and adipokines do not seem to be the primary drivers of persistent respiratory issues post-bronchiolitis.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
336
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
502
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K